why choose us

First received: October 27, 2022

Clinical Trial: A Study of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Non-cystic Fibrosis Bronchiectasis (NCFBE)

Study Type: INTERVENTIONAL


Official Title: Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-cystic Fibrosis Bronchiectasis

Brief Summary: This is a phase II, randomised, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.

Read more